Literature DB >> 29939149

Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.

Lorenz Räber1, Gary S Mintz, Konstantinos C Koskinas, Thomas W Johnson, Niels Ramsing Holm, Yoshinobu Onuma, Maria D Radu, Michael Joner, Bo Yu, Haibo Jia, Nicolas Meneveau, Jose Maria de la Torre Hernandez, Javier Escaned, Jonathan Hill, Francesco Prati, Antonio Colombo, Carlo Di Mario, Evelyn Regar, Davide Capodanno, William Wijns, Robert A Byrne, Giulio Guagliumi.   

Abstract

This Consensus Document is the first of two reports summarizing the views of an expert panel organized by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on the clinical use of intracoronary imaging including intravascular ultrasound (IVUS) and optical coherence tomography (OCT). The first document appraises the role of intracoronary imaging to guide percutaneous coronary interventions (PCIs) in clinical practice. Current evidence regarding the impact of intracoronary imaging guidance on cardiovascular outcomes is summarized, and patients or lesions most likely to derive clinical benefit from an imaging-guided intervention are identified. The relevance of the use of IVUS or OCT prior to PCI for optimizing stent sizing (stent length and diameter) and planning the procedural strategy is discussed. Regarding post-implantation imaging, the consensus group recommends key parameters that characterize an optimal PCI result and provides cut-offs to guide corrective measures and optimize the stenting result. Moreover, routine performance of intracoronary imaging in patients with stent failure (restenosis or stent thrombosis) is recommended. Finally, strengths and limitations of IVUS and OCT for guiding PCI and assessing stent failures and areas that warrant further research are critically discussed.

Entities:  

Mesh:

Year:  2018        PMID: 29939149     DOI: 10.4244/EIJY18M06_01

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  13 in total

1.  An assessment of the quality of optical coherence tomography image acquisition.

Authors:  Elder Iarossi Zago; Abdul Jawwad Samdani; Gabriel Tensol Rodrigues Pereira; Armando Vergara-Martel; Mohamad Amer Alaiti; Luis Augusto Dallan; Patricia Ely Pizzato; Vladislav Zimin; Anas Fares; Hiram G Bezerra
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-18       Impact factor: 2.357

Review 2.  Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials.

Authors:  Abdelhakim Allali; Mohamed Abdel-Wahab; Karim Elbasha; Nader Mankerious; Hussein Traboulsi; Adnan Kastrati; Mohamed El-Mawardy; Rayyan Hemetsberger; Dmitriy S Sulimov; Franz-Josef Neumann; Ralph Toelg; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2022-04-28       Impact factor: 5.460

3.  Stent Optimization Using Optical Coherence Tomography and Its Prognostic Implications After Percutaneous Coronary Intervention.

Authors:  Himanshu Rai; Fiona Harzer; Tatsuhiko Otsuka; Youssef S Abdelwahed; Paula Antuña; Florian Blachutzik; Tobias Koppara; Lorenz Räber; David M Leistner; Fernando Alfonso; Holger Nef; Masaru Seguchi; Alp Aytekin; Erion Xhepa; Sebastian Kufner; Salvatore Cassese; Karl-Ludwig Laugwitz; Robert A Byrne; Adnan Kastrati; Michael Joner
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

4.  XLIMus drug eluting stent: A randomIzed controlled Trial to assess endothelialization. The XLIMIT trial.

Authors:  Luca Testa; Gaetano Pero; Mario Bollati; Matteo Casenghi; Antonio Popolo Rubbio; Magdalena Cuman; Raul Moreno; Antoni Serra; Joan Antoni Gomez; Francesco Bedogni
Journal:  Int J Cardiol Heart Vasc       Date:  2019-04-28

5.  Prognostic irrelevance of plaque vulnerability following plaque sealing in high-risk patients with type 2 diabetes: an optical coherence tomography study.

Authors:  Rosalia Dettori; Andrea Milzi; Kathrin Burgmaier; Mohammad Almalla; Martin Hellmich; Nikolaus Marx; Sebastian Reith; Mathias Burgmaier
Journal:  Cardiovasc Diabetol       Date:  2020-11-12       Impact factor: 9.951

6.  Diagnostic Performance of Frequency-Domain Optical Coherence Tomography to Predict Functionally Significant Left Main Coronary Artery Stenosis.

Authors:  Konstantina P Bouki; Delia I Vlad; Nikolaos Goulas; Vaia A Lambadiari; George D Dimitriadis; Athanasios A Kotsakis; Kyriaki Barοutsi; Konstantinos P Toutouzas
Journal:  J Interv Cardiol       Date:  2021-11-15       Impact factor: 2.279

7.  Feasibility and safety of minimal-contrast IVUS-guided rotational atherectomy for complex calcified coronary artery disease.

Authors:  Abdelhakim Allali; Hussein Traboulsi; Dmitriy S Sulimov; Mohamed Abdel-Wahab; Felix Woitek; Norman Mangner; Rayyan Hemetsberger; Nader Mankerious; Karim Elbasha; Ralph Toelg; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2021-07-13       Impact factor: 5.460

8.  OCT-Derived Plaque Morphology and FFR-Determined Hemodynamic Relevance in Intermediate Coronary Stenoses.

Authors:  Mariusz Tomaniak; Dorota Ochijewicz; Łukasz Kołtowski; Adam Rdzanek; Arkadiusz Pietrasik; Jacek Jąkała; Magdalena Slezak; Krzysztof P Malinowski; Martyna Zaleska; Jakub Maksym; Piotr Barus; Tomasz Roleder; Krzysztof J Filipiak; Grzegorz Opolski; Janusz Kochman
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

Review 9.  Contemporary Approach to Heavily Calcified Coronary Lesions.

Authors:  Carlotta Sorini Dini; Giulia Nardi; Francesca Ristalli; Alessio Mattesini; Brunilda Hamiti; Carlo Di Mario
Journal:  Interv Cardiol       Date:  2019-11-18

10.  Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study.

Authors:  Fuxue Deng; Danni Li; Lei Lei; Qiang Yang; Qing Li; Hongtao Wang; Jie Deng; Qiangsun Zheng; Wei Jiang
Journal:  Cardiovasc Diabetol       Date:  2021-09-15       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.